Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents

Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (46)

  1. Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use. 2025-06-01 · Expand citations
  2. Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study. 2025-02-01 · Expand citations
  3. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. 2023-10-01 · Expand citations
  4. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. 2023-01-01 · Expand citations
  5. Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. 2022-11-01 · Expand citations
  6. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. 2022-05-01 · Expand citations
  7. "A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use. 2022-01-01 · Expand citations
  8. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  9. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  10. Psilocybin: from ancient magic to modern medicine. 2020-10-01 · Expand citations
  11. Emotions and brain function are altered up to one month after a single high dose of psilocybin. 2020-02-10 · Expand citations
  12. Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame 2019-11-05 · Expand citations
  13. Neuroticism is associated with challenging experiences with psilocybin mushrooms. 2017-10-15 · Expand citations
  14. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. 2017-07-01 · Expand citations
  15. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  16. Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
  17. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  18. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  19. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. 2016-12-01 · Expand citations
  20. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  21. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  22. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  23. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  24. OpenAlex W1971841445
  25. OpenAlex W1979290264
  26. OpenAlex W2078821747
  27. OpenAlex W2087848624
  28. OpenAlex W2102059582
  29. OpenAlex W2164276826
  30. OpenAlex W2744933359
  31. OpenAlex W2788854095
  32. OpenAlex W2885455509
  33. OpenAlex W2887938296
  34. OpenAlex W2954690399
  35. OpenAlex W2965468106
  36. OpenAlex W2973627003
  37. OpenAlex W3049156731
  38. OpenAlex W3087672006
  39. OpenAlex W3092548915
  40. OpenAlex W4220656556
  41. OpenAlex W4220776312
  42. OpenAlex W4399071817
  43. OpenAlex W4400279567
  44. OpenAlex W4403366569
  45. OpenAlex W4406955835
  46. OpenAlex W4411462140

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.